News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Medgenics, Inc. Extends Collaboration with Baxter Healthcare Corporation on Development of Factor VIII Biopump
July 6, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MISGAV, Israel and VIENNA, Va.--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) announces an extension of its agreement with Baxter Healthcare Corporation for the joint development of the Factor VIII Biopump.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
MORE ON THIS TOPIC
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
December 22, 2025
·
1 min read
·
Annalee Armstrong
Business
BioSpace
Editors’ Top 5 Biggest News Stories of the Year
December 22, 2025
·
10 min read
·
Annalee Armstrong
Layoff Tracker
Voyager Loses 30 Employees After Novartis Prunes Deal
December 19, 2025
·
98 min read
·
BioSpace Editorial Staff
Rare diseases
Kyowa Kirin Could Get Windfall From Updated Newborn Screening Recommendations
December 19, 2025
·
2 min read
·
Dan Samorodnitsky